Long‐term cost‐effectiveness analysis of sacral neuromodulation in the treatment of severe faecal incontinence
- 7 August 2023
- journal article
- research article
- Published by Wiley in Colorectal Disease
- Vol. 25 (9) , 1821-1831
Abstract
Aim: The aim of this study was to evaluate the long‐term cost‐effectiveness of sacral neuromodulation in the treatment of severe faecal incontinence as compared with symptomatic management.Methods: In the public health field, a micro‐costing evaluation method was conducted from the perspectives of the health system and the society. The incremental cost‐effectiveness ratio was used as a decision index, and we considered various scenarios to evaluate the impact of the cost of symptomatic management and percutaneous nerve evaluation success rate in its calculation. Clinical data were retrieved from a consecutive cohort of 93 patients with severe faecal incontinence undergoing sacral neuromodulation after a failure of conservative (pharmacological and biofeedback) and/or surgical (sphincteroplasty) first‐line treatments were considered.Results: The long‐term incremental cost‐effectiveness ratio comparing sacral neuromodulation versus symptomatic management was 14347€/QALY and 28523€/QALY from the societal and health service provider's perspectives, respectively. If the definitive pulse generator implant success rate was 100%, incremental cost‐effectiveness would correspond to 6831€/QALY and 16761€/QALY, respectively.Conclusions: Sacral neuromodulation may be considered a cost‐effective technique in the long‐term treatment of severe faecal incontinence from the societal and health care sector perspectives. Improving patient selection and determining the predictive outcome factors for successful sacral neuromodulation in the treatment of faecal incontinence would improve cost‐effectiveness.Keywords
This publication has 45 references indexed in Scilit:
- Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)Quality of Life Research, 2011
- Outcome and Cost Analysis of Sacral Nerve Modulation for Treating Urinary and/or Fecal IncontinenceAnnals of Surgery, 2011
- Sacral Neuromodulation for the Treatment of Fecal Incontinence: Analysis of Cost-EffectivenessDiseases of the Colon & Rectum, 2010
- Clinical and cost effectiveness of sacral nerve stimulation for faecal incontinenceBritish Journal of Surgery, 2008
- Adaptation to Spanish Language and Validation of the Fecal Incontinence Quality of Life ScaleDiseases of the Colon & Rectum, 2006
- Costs of outpatients with fecal incontinenceScandinavian Journal of Gastroenterology, 2005
- Using covariates to reduce uncertainty in the economic evaluation of clinical trial dataHealth Economics, 2004
- Use of Cost-Effectiveness Analysis in Health-Care Resource Allocation Decision-Making: How Are Cost-Effectiveness Thresholds Expected to Emerge?Value in Health, 2004
- Fecal incontinence quality of life scaleDiseases of the Colon & Rectum, 2000
- Long-term cost of fecal incontinence secondary to obstetric injuriesDiseases of the Colon & Rectum, 1999